Aju Ib Investment Co., Ltd. Rapt Therapeutics, Inc. Transaction History
Aju Ib Investment Co., Ltd.
- $115 Million
- Q3 2025
A detailed history of Aju Ib Investment Co., Ltd. transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Aju Ib Investment Co., Ltd. holds 12,437 shares of RAPT stock, worth $358,807. This represents 0.28% of its overall portfolio holdings.
Number of Shares
12,437
Previous 12,437
-0.0%
Holding current value
$358,807
Previous $99,000
223.23%
% of portfolio
0.28%
Previous 0.11%
Shares
3 transactions
Others Institutions Holding RAPT
# of Institutions
13Shares Held
8.03MCall Options Held
0Put Options Held
0-
Medicxi Ventures Management (Jersey) LTD2.79MShares$80.6 Million10.91% of portfolio
-
Black Rock Inc. New York, NY2.44MShares$70.4 Million0.0% of portfolio
-
Ponoi Management, LLC San Francisco, CA1.6MShares$46.1 Million52.54% of portfolio
-
Kpcb Xv Associates, LLC649KShares$18.7 Million43.54% of portfolio
-
Column Group LLC San Francisco, CA166KShares$4.79 Million5.41% of portfolio
About RAPT Therapeutics, Inc.
- Ticker RAPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,656,600
- Market Cap $856M
- Description
- RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...